Evidence map›Paper›PMID 34797774›Full record

Observational studyJMIR public health and surveillance2022

Individuals With SARS-CoV-2 Infection During the First and Second Waves in Catalonia, Spain: Retrospective Observational Study Using Daily Updated Data.

Lia Alves-Cabratosa, Marc Comas-Cufí, Jordi Blanch, Ruth Martí-Lluch, Anna Ponjoan, Antoni Castro-Guardiola, Abelardo Hurtado-Ganoza, Ana Pérez-Jaén, Maria Rexach-Fumaña, Delfi Faixedas-Brunsoms and 18 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in JMIR public health and surveillance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical Presentation and Outcome of Hospitalized Patients With COVID-19 in the First and Second Waves in Saudi Arabia.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 1 country.

Lia Alves-CabratosaVascular Health Research Group of Girona, Institut Universitari per a la Recerca en Atenció Primària Jordi Gol i Gurina, Girona, Spain.ORCID 0000-0002-5006-952X
Marc Comas-CufíVascular Health Research Group of Girona, Institut Universitari per a la Recerca en Atenció Primària Jordi Gol i Gurina, Girona, Spain.ORCID 0000-0001-9759-0622
Jordi BlanchVascular Health Research Group of Girona, Institut Universitari per a la Recerca en Atenció Primària Jordi Gol i Gurina, Girona, Spain.ORCID 0000-0001-8211-3292
Ruth Martí-LluchVascular Health Research Group of Girona, Institut Universitari per a la Recerca en Atenció Primària Jordi Gol i Gurina, Girona, Spain.ORCID 0000-0002-7320-9521
Anna PonjoanVascular Health Research Group of Girona, Institut Universitari per a la Recerca en Atenció Primària Jordi Gol i Gurina, Girona, Spain.ORCID 0000-0003-4314-6387
Antoni Castro-GuardiolaInstitut d'Investigació Biomèdica de Girona, Girona, Spain.ORCID 0000-0001-5407-939X
Abelardo Hurtado-GanozaInstitut d'Investigació Biomèdica de Girona, Girona, Spain.ORCID 0000-0002-4248-1418
Ana Pérez-JaénInternal Medicine Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0001-8940-0809
Maria Rexach-FumañaInstitut d'Investigació Biomèdica de Girona, Girona, Spain.ORCID 0000-0002-3985-3161
Delfi Faixedas-BrunsomsTechnical Secretariat, Institut Assistència Sanitària, Girona, Spain.ORCID 0000-0001-9347-793X
Maria Angels Gispert-AmetllerDepartment of Medical Sciences, University of Girona, Girona, Spain.ORCID 0000-0001-8554-6202
Anna Guell-CargolEmergency Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0003-2034-0013
Maria Rodriguez-BatistaEmergency Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0001-6927-6126
Ferran Santaularia-FontEmergency Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0001-7547-9296
Ramon OrriolsInstitut d'Investigació Biomèdica de Girona, Girona, Spain.ORCID 0000-0001-8498-5115
Marc Bonnin-VilaplanaInstitut d'Investigació Biomèdica de Girona, Girona, Spain.ORCID 0000-0002-1733-3448
Juan Carlos Calderón LópezInstitut d'Investigació Biomèdica de Girona, Girona, Spain.ORCID 0000-0003-4262-2628
Gladis Sabater-TalaveranoInstitut d'Investigació Biomèdica de Girona, Girona, Spain.ORCID 0000-0001-6554-0794
Francesc Xavier Queralt MolesTerritorial Clinical Laboratory of Girona, Parc Hospitalari Martí i Julià, Salt, Spain.ORCID 0000-0001-6176-2285
Sara Rodriguez-RequejoAtenció Primària, Institut Català de la Salut, Girona, Spain.ORCID 0000-0001-9871-8595
Esteve Avellana-RevueltaAtenció Primària, Institut Català de la Salut, Girona, Spain.ORCID 0000-0002-7527-0916
Elisabet BallóDepartment of Medical Sciences, University of Girona, Girona, Spain.ORCID 0000-0002-5216-0765
Ester Fages-MasmiquelAtenció Primària, Institut Català de la Salut, Girona, Spain.ORCID 0000-0001-5662-1947
Josep-Maria SirventIntensive Care Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0002-7485-0652
Carol LorencioIntensive Care Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0002-9237-5541
Josep Miquel Morales-PedrosaIntensive Care Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0001-8165-373X
Patricia Ortiz-BallujeraIntensive Care Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain.ORCID 0000-0002-5356-661X
Rafel RamosVascular Health Research Group of Girona, Institut Universitari per a la Recerca en Atenció Primària Jordi Gol i Gurina, Girona, Spain.ORCID 0000-0001-7970-5537
Hospital Universitari de Girona Doctor Josep Trueta · ESUniversitat de Girona · ESInstitut d'Investigació Biomèdica de Girona · ESInstitut Català de la Salut · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA description of individuals with SARS-CoV-2 infection comparing the first and second waves could help adapt health services to manage this highly transmissible infection.

objectiveWe aimed to describe the epidemiology of individuals with suspected SARS-CoV-2 infection, and the characteristics of patients with a positive test comparing the first and second waves in Catalonia, Spain.

methodsThis study had 2 stages. First, we analyzed daily updated data on SARS-CoV-2 infection in individuals from Girona (Catalonia). Second, we compared 2 retrospective cohorts of patients with a positive reverse-transcription polymerase chain reaction or rapid antigen test for SARS-CoV-2. The severity of patients with a positive test was defined by their admission to hospital, admission to intermediate respiratory care, admission to the intensive care unit, or death. The first wave was from March 1, 2020, to June 24, 2020, and the second wave was from June 25, 2020, to December 8, 2020.

resultsThe numbers of tests and cases were lower in the first wave than in the second wave (26,096 tests and 3140 cases in the first wave versus 140,332 tests and 11,800 cases in the second wave), but the percentage of positive results was higher in the first wave than in the second wave (12.0% versus 8.4%). Among individuals with a positive diagnostic test, 818 needed hospitalization in the first wave and 680 in the second; however, the percentage of hospitalized individuals was higher in the first wave than in the second wave (26.1% versus 5.8%). The group that was not admitted to hospital included older people and those with a higher percentage of comorbidities in the first wave, whereas the characteristics of the groups admitted to hospital were more alike.

conclusionsScreening systems for SARS-CoV-2 infection were scarce during the first wave, but were more adequate during the second wave, reflecting the usefulness of surveillance systems to detect a high number of asymptomatic infected individuals and their contacts, to help control this pandemic. The characteristics of individuals with SARS-CoV-2 infection in the first and second waves differed substantially; individuals in the first wave were older and had a worse health condition.

Indexed as

COVID-19AgedDiagnostic Tests, RoutineHumansRetrospective StudiesSARS-CoV-2SpaincomparisonCOVID-19epidemiologypandemicpopulation characteristicsSARS-CoV-2timelinewaves

Identifiers

PMID34797774
PMCPMC8734611
OpenAlexW3213560681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.